ABXL vs CME · rev $235.2M vs P/E 22, rev $3.59B
ABXL (ABXL) versus CME Group Inc (CME) — a side-by-side from cached financials, not a winner call.
ABXL (ABXL) common stock listed on NYSE.
CME Group Inc (CME) is a financial data & stock exchanges company listed on NASDAQ.
Latest reported ABXL revenue for 2025-12-31 was $235.2M. Net income was $36.5M. Revenue was up 110.2% from 2024-12-31 to 2025-12-31. ABXL currently screens at market cap $0.
Latest reported CME revenue for 2026-06-30 was $3.59B. Net income was $2.20B. Revenue was up 90.8% from 2026-03-31 to 2026-06-30. CME currently screens at market cap $91.25B and trailing P/E 21.9.
ABXL currently screens at market cap $0. CME currently screens at market cap $91.25B and trailing P/E 21.9.
Not investment advice. Open the ABXL and CME stock pages for the full models.
Not investment advice.